scientific article; zbMATH DE number 932672

From MaRDI portal
Revision as of 05:34, 8 February 2024 by Import240129110113 (talk | contribs) (Created automatically from import240129110113)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Publication:4894950

zbMath0870.92006MaRDI QIDQ4894950

Rory Martin, Kok Lay Teo

Publication date: 8 October 1996


Title: zbMATH Open Web Interface contents unavailable due to conflicting licenses.



Related Items (46)

Evaluating the efficacies of maximum tolerated dose and metronomic chemotherapies: a mathematical approachMixed immunotherapy and chemotherapy of tumors: feedback design and model updating schemesOPTIMAL CONTROL OF MULTIPLE-TIME DELAYED SYSTEMS BASED ON THE CONTROL PARAMETERIZATION METHODOptimization of virotherapy for cancerON OPTIMAL CHEMOTHERAPY FOR HETEROGENEOUS TUMORSThe Structure of Optimal Protocols for a Mathematical Model of Chemotherapy with Antiangiogenic EffectsOptimal control of cancer chemotherapy with delays and state constraintsOptimal chemotherapy schedules from tumor entropyGenerating locally optimal trajectories for an automatically driven carUnnamed ItemConstrained bilinear control problem: Application to a cancer chemotherapy modelMathematical modeling and optimal control problems in brain tumor targeted drug delivery strategiesSparse control for continuous‐time systemsCombination of antiangiogenic treatment with chemotherapy as a multi‐input optimal control problemOptimal control problems for differential equations applied to tumor growth: state of the artControl parameterization approach to time-delay optimal control problems: a surveyCompetition between populations: preventing domination of resistant population using optimal controlTime-optimal hands-off control for linear time-invariant systemsDynamical behaviour of a tumor-immune system with chemotherapy and optimal controlA survey of optimization models on cancer chemotherapy treatment planningCatalog of the optimal controls in cancer chemotherapy for the Gompertz model depending on PK/PD and the integral constraintOptimal control problems with incomplete and different integral time domains in the objective and constraintsDynamic optimization of dual-mode hybrid systems with state-dependent switching conditionsAn optimal machine maintenance problem with probabilistic state constraintsMixed-Effects State-Space Models for Analysis of Longitudinal Dynamic SystemsOptimal control of treatment in a mathematical model of chronic myelogenous leukemiaControl parameterization enhancing transform for optimal control of switched systemsModeling and control of pharmacodynamicsMulti-modal control using adaptive motion description languagesOptimisation modelling of cancer growthOptimal control problems arising in the zinc sulphate electrolyte purification processSimple ODE models of tumor growth and anti-angiogenic or radiation treatmentRecovery of normal hemopoiesis in disseminated cancer therapy -- a modelOn the role of the objective in the optimization of compartmental models for biomedical therapiesOptimal control problems with multiple characteristic time points in the objective and constraintsDynamic response of cancer under the influence of immunological activity and therapyVisual MISER: an efficient user-friendly visual program for solving optimal control problemsControl variable parameterisation with penalty approach for hypersonic vehicle reentry optimisationNumerical optimal control of a size-structured PDE model for metastatic cancer treatmentGenetic algorithms for modelling and optimisationOptimal control for a mathematical model for chemotherapy with pharmacometricsRobust optimization for a nonlinear switched time-delay system with noisy output measurements using hybrid optimization algorithmA 3-compartment model for chemotherapy of heterogeneous tumor populationsA cellular automata model of chemotherapy effects on tumour growth: targeting cancer and immune cellsOptimal control oriented to therapy for a free-boundary tumor growth modelApplication of optimal control theory to analysis of cancer chemotherapy regimens







This page was built for publication: